iAnthus Capital Holdings, Inc. (ITHUF)
iAnthus Capital Holdings, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.00, up 2.56% on the session, giving a market capitalisation of $27.9M. On trailing twelve-month figures it carries a trailing P/E of -0.49, a net margin of -39.5%. Its beta of -0.73 implies it has historically moved less than the broad market.
iAnthus Capital Holdings, Inc. manages and operates a network of licensed cannabis cultivation, processing, and retail dispensary facilities across the United States. The company's diverse product portfolio includes raw cannabis biomass such as pre-rolls, various cannabis-infused items like topical creams and edibles, and a selection of concentrated products such as vape cartridges, live resins, waxes, oils, and tinctures. They also produce and distribute a range of cannabidiol (CBD) products, including topical creams, tinctures, and sprays, alongside a dedicated line of CBD-infused beauty and skincare essentials like lotions, creams, haircare items, lip balms, and bath bombs. iAnthus participates in both the wholesale distribution and direct-to-consumer retail of its CBD offerings. Its operational footprint spans 8 states, encompassing ownership or management of 32 dispensaries and 10 cultivation or processing sites. Founded in 2014, the company is headquartered in New York, New York.
iAnthus Capital Holdings, Inc. is most often compared with the following Healthcare names: